Jia Wei joined Sonoma in October 2021 as Principal Scientist in Product Science with about 20 years of scientific experience, including eight years of expertise in CAR-T cell engineering and therapy development in Michael Jensen’s lab at Seattle Children’s. She designed a synthetic promoter library and successfully screened out CAR/TCR activation specific promoters which will be applied to CAR-T cell clinical trials as a safety switch. She also investigated on non-viral delivery systems for CAR and its payload. Prior to her eight-year tenure at Children’s, she was a R&D scientist at Life Technologies (Invitrogen) and the main contributor for developing Lipofectamine 3000, a high performance, broad spectrum transfection reagent for a variety of cell types and lentiviral production.
Wei received her PhD degree from Georgia Institute of Technology in Molecular and Cell Biology and had her postdoc training at the Script Research Institute working on elucidating a cell signaling pathway for B cell antigen receptor editing.